Greg Fenner

Greg Fenner has an extensive background in the pharmaceutical industry, holding various sales and leadership positions in companies such as Acadia Pharmaceuticals Inc., Alcresta Therapeutics, and Braeburn. With a degree from Harvard Business School focusing on Leadership and Strategy in Pharmaceuticals and Biotech, Greg has a strong foundation in the industry. Prior to their current role, Greg served as the Regional Business Director at Sage Therapeutics and the Sr. Sales Director, East at Novelion Therapeutics. Greg's experience also includes positions at Dyax and Centocor, where Greg held national sales director roles.